Literature DB >> 9317067

Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood.

R Roosendaal1, E J Kuipers, J Buitenwerf, C van Uffelen, S G Meuwissen, G J van Kamp, C M Vandenbroucke-Grauls.   

Abstract

OBJECTIVE: To investigate whether the decrease in rate of Helicobacter pylori infection in subsequent birth cohorts has continued during the last decades.
METHODS: Determination by ELISA of IgG H. pylori antibodies in 314 serum samples from Dutch children (age 6-8 yr, n = 154) and young adolescents (age 12-15 yr, n = 160), collected in 1978 and 1993.
RESULTS: The prevalence of H. pylori declined from 19% to 9% at age 6-8 yr and from 23% to 11% at age 12-15 yr. For the whole study population, a decline from 21% to 10% (p = 0.01) was observed between 1978 and 1993. On the basis of these data and an incidence of infection with H. pylori of 0.3% per year during the same period, a model for both past and future prevalence rates of H. pylori in the Dutch population was calculated. The outcome demonstrates a decrease from more than 50% around World War II to less than 20% for the whole population around year 2040.
CONCLUSIONS: H. pylori infection rates in childhood have continued to decline until recent decades, demonstrating a persistent birth cohort effect. This decline will result in a very low prevalence of H. pylori infection in the Dutch population during the next decades, becoming even lower as the observed decline in children and young adolescents continues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317067

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  45 in total

Review 1.  Helicobacter pylori-reflections for the next millennium.

Authors:  G N Tytgat
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 2.  Helicobacter pylori infection and eradication in paediatric patients.

Authors:  H M Malaty
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

3.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

4.  Motor fluctuations and Helicobacter pylori in Parkinson's disease.

Authors:  Karl-Erik Rahne; Carl Tagesson; Dag Nyholm
Journal:  J Neurol       Date:  2013-09-04       Impact factor: 4.849

Review 5.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 6.  Helicobacter pylori infection and extragastric disorders in children: a critical update.

Authors:  Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Helicobacter pylori infection in pregnant women from a U.S.-Mexico border population.

Authors:  Karen J Goodman; Kathleen O'Rourke; R Sue Day; Constance Wang; Thomas Redlinger; Armando Campos; Jose Manuel de la Rosa
Journal:  J Immigr Health       Date:  2003-07

Review 8.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

9.  High prevalence of gastroesophageal reflux symptoms in patients with both acute and nonacute cough.

Authors:  Yoshihisa Urita; Toshiyasu Watanabe; Hiroki Ota; Motohide Iwata; Yosuke Sasaki; Tadashi Maeda; Takamasa Ishii; Makie Nanami; Asuka Nakayama; Hirohito Kato; Kazuo Hike; Noriko Hara; Masaki Sanaka; Yoko Nagai; Shuji Watanabe; Kazushige Nakanishi; Hitoshi Nakajima; Motonobu Sugimoto
Journal:  Int J Gen Med       Date:  2008-11-30

10.  Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.

Authors:  Michael Hermansson; Anders Ekedahl; Jonas Ranstam; Thomas Zilling
Journal:  BMC Gastroenterol       Date:  2009-04-20       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.